Gilead Sciences commences HIV drug trial
GS-7340 is a nucleotide reverse transcriptase inhibitor (NtRTI) similar to the company’s HIV drug Viread. The double-blind 48-week clinical trial will include150 patients, who are randomized (2:1) to
BeOne Medicines is set to invest $300m in expanding its manufacturing and research operations at the Princeton West Innovation Campus in Hopewell, New Jersey, US.
NextDocs’solutions can ensure users the consistency of workflow processes and document handling, with the capability of re-engineering business processes using workflow controls if necessary. In addition, NextDocs’ collection